About 40 percent of head and neck cancer survivors do not return to work
the ONA take:
According to a study published in the journal Head & Neck, researchers from Jena University Hospitial and University Medical Centre in Germany have found that many survivors of head and neck cancer do not return to work.
For the exploratory study, researchers identified 55 head and neck cancer survivors no older than 60 years of age.
All participants completed a survey that included subscales from various health questionnaires. Results showed that the rate of employed patients decreased from 75% of patients prior to diagnosis to 33% at an average of 66.8 months following diagnosis.
Researchers found that current employment was associated with more difficult physical work prior to diagnosis, surgical treatment, and current risky consumption of alcohol.
The study also showed that unemployed survivors reported decreased functional and social well-being scores and increased depression scores.
The findings suggest that psychosocial variables were significantly associated to employment, but the authors note that further research is necessary to evaluate these relationships.
Many survivors of head and neck cancer do not return to work.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- Neuropathic Cancer Pain Linked to Reduced Quality of Life
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|